Importance Major depressive disorder (MDD) affects approximately 10% of the population
globally. Approximately 20% to 30% of patients with MDD do not sufficiently respond to …

Depression, either bipolar or unipolar, is a highly prevalent and disabling condition. Even
though several treatment options exist for depressed patients, a significant portion of …

Given the high prevalence of individuals diagnosed with substance use disorder, along with
the elevated rate of relapse following treatment initiation, investigating novel approaches …

We reviewed novel brain stimulation approaches that modify neuroplasticity and are used in
the treatment and study of schizophrenia. We searched PubMed and Scholars Portal using …

Deep brain stimulation (DBS) is an emerging interventional therapy for well-screened
patients with specific treatment-resistant neuropsychiatric diseases. Some neuropsychiatric …

This ECNP meeting was designed to build bridges between different constituencies of
mental illness treatment researchers from a range of backgrounds with a specific focus on …

Interest in neurostimulation interventions has significantly grown in recent decades, yet a
scientometric analysis objectively mapping scientific knowledge and recent trends remains …

Background Depression rates have reached historic highs, with 49% of Americans reporting
unabating symptoms and signs of depression, representing a 12% increase compared to the …

Background Evidence suggests that schizophrenia constitutes a neurodevelopmental
disorder, characterized by a gradual emergence of behavioral and neurobiological …

Objective: To analyze the safety and efficacy of repetitive transcranial magnetic stimulation
(rTMS) for major depressive disorder, schizophrenia, and obsessive-compulsive disorder …